SERACTIL

This brand name is authorized in Austria, Spain, Poland, Romania

Active ingredients

The drug SERACTIL contains one active pharmaceutical ingredient (API):

1 Dexibuprofen UNII 671DKG7P5S - DEXIBUPROFEN

Dexibuprofen is considered to be the pharmacologically active enantiomer of racemic ibuprofen. Racemic ibuprofen is a non-steroidal substance with antiinflammatory and analgesic effects. Its mechanism of action is thought to be due to inhibition of prostaglandin synthesis. Read about Dexibuprofen

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
SERACTIL Film-coated tablet	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
M01AE14	Dexibuprofen	M Musculo-skeletal system → M01 Antiinflammatory and antirheumatic products → M01A Antiinflammatory and antirheumatic products, non-steroids → M01AE Propionic acid derivatives
Discover more medicines within M01AE14

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 63574
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100098562, 100098585
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W63988001, W63988002, W63988003, W63988004, W63988005, W63988006, W63988007, W63988008, W63988009, W63988010